Description

This webinar will cover new insights into the world of asbestos science. Experts will discuss recent developments, scientific findings, and the regulatory stance on this topic. The program is recommended for attorneys and claims professionals involved in mesothelioma, talc, and general toxic tort claims.

Who Should Attend

• Attorneys who deal with toxic tort cases and/or insurance companies

What You Will Learn

• Our first presenter will discuss the evaluation of Libby amphibole no-observed-adverse-effect level (NOAEL) and the lowest-observed-adverse-effect level (LOAEL) for mesothelioma
• Our second presenter will provide an overview of FDA's cosmetic talc analytical findings from 1971 until present
• Our final presenter will provide a synopsis of the FDA's public meeting on testing methods for asbestos in talc

Speaker(s):

• A. M. Lerardi, MES, MS, Cardno ChemRisk
• Jason Lotter, MS, CIH, Cardno ChemRisk
• Claire Mathis, MPH, Cardno ChemRisk